Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients
about
SOD1 Transcriptional and Posttranscriptional Regulation and Its Potential Implications in ALSIncreased functional connectivity common to symptomatic amyotrophic lateral sclerosis and those at genetic riskOxidative Stress in Neurodegenerative DiseasesMolecular motor proteins and amyotrophic lateral sclerosisConverging mechanisms in ALS and FTD: disrupted RNA and protein homeostasisRedox regulation in amyotrophic lateral sclerosisTempol moderately extends survival in a hSOD1(G93A) ALS rat model by inhibiting neuronal cell loss, oxidative damage and levels of non-native hSOD1(G93A) formsAggregation-triggering segments of SOD1 fibril formation support a common pathway for familial and sporadic ALSThe Cu, Zn Superoxide Dismutase: Not Only a Dismutase EnzymeEmerging mechanisms of molecular pathology in ALSCalcium dysregulation links ALS defective proteins and motor neuron selective vulnerabilityPyrimethamine decreases levels of SOD1 in leukocytes and cerebrospinal fluid of ALS patients: a phase I pilot studyClinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosisAberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosisSolid-state NMR studies of metal-free SOD1 fibrillar structures.Intermolecular transmission of superoxide dismutase 1 misfolding in living cells.Cutting off functional loops from homodimeric enzyme superoxide dismutase 1 (SOD1) leaves monomeric β-barrels.A random set scoring model for prioritization of disease candidate genes using protein complexes and data-mining of GeneRIF, OMIM and PubMed records.Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants.Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosisProtein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia ContinuumCharacterization of thoracic motor and sensory neurons and spinal nerve roots in canine degenerative myelopathy, a potential disease model of amyotrophic lateral sclerosis.Protease-resistant SOD1 aggregates in amyotrophic lateral sclerosis demonstrated by paraffin-embedded tissue (PET) blot.Cu, Zn-superoxide dismutase 1 (SOD1) is a novel target of Puromycin-sensitive aminopeptidase (PSA/NPEPPS): PSA/NPEPPS is a possible modifier of amyotrophic lateral sclerosis.Identification of a misfolded region in superoxide dismutase 1 that is exposed in amyotrophic lateral sclerosis.IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients.Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis.Identification of human monoclonal antibodies specific for human SOD1 recognizing distinct epitopes and forms of SOD1.Repetitive nerve stimulation transiently opens the mitochondrial permeability transition pore in motor nerve terminals of symptomatic mutant SOD1 miceThe carbonylation and covalent dimerization of human superoxide dismutase 1 caused by its bicarbonate-dependent peroxidase activity is inhibited by the radical scavenger tempol.Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis.Altered intracellular localization of SOD1 in leukocytes from patients with sporadic amyotrophic lateral sclerosis.Proteins that bind to misfolded mutant superoxide dismutase-1 in spinal cords from transgenic amyotrophic lateral sclerosis (ALS) model mice.Early-stage treatment with Withaferin A reduces levels of misfolded superoxide dismutase 1 and extends lifespan in a mouse model of amyotrophic lateral sclerosis.Genotype-property patient-phenotype relations suggest that proteome exhaustion can cause amyotrophic lateral sclerosis.Direct and indirect mechanisms for wild-type SOD1 to enhance the toxicity of mutant SOD1 in bigenic transgenic mice.Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1.Structural and kinetic analysis of protein-aggregate strains in vivo using binary epitope mappingSubstantially elevating the levels of αB-crystallin in spinal motor neurons of mutant SOD1 mice does not significantly delay paralysis or attenuate mutant protein aggregation.Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states
P2860
Q21296781-1B1380F3-9C8C-447B-AEF1-6F6F759ED80FQ24658568-8E1F6D5A-B592-4155-942B-F8F3B7B71BB8Q26801239-61C5F139-79A8-425B-85AF-839B56A906FCQ26820831-C7DDEAD1-47A5-470A-B84F-50375E260352Q26863439-39E5A22D-6F59-4DEE-98EF-4DCDAE3CC12BQ27026894-6CF9D439-2500-408B-B426-0AF9B53D204DQ27315986-835BE56B-C7E0-469F-B472-F9D3F97E370AQ27680903-AB5179C5-9812-4BC8-9A3F-D7CDC5BFC63BQ28076049-EAE6B4AB-035B-4DA1-9063-4510E4DFAF6BQ28081239-C2D5AFFC-ECBC-4A7C-9C5A-F22F4437A8ADQ28084373-C96CAFE4-2DE3-4B57-A755-97D51CD323D0Q28275227-74FF559F-E2A9-43A3-9F2B-BD5021E3E172Q28392768-86CFC8EF-8316-4403-887E-2A927FB84FC1Q28730723-8B59C9EF-A528-4EB3-8003-36B7EFD0FED3Q30153414-7382E0D6-B7E2-4279-8408-0333CA5332D8Q30155471-DD178D75-9B8A-4E50-8841-F9BF03D3EB03Q30155526-24B80B8B-5D64-49C9-9975-A28E56071135Q30855078-795CA78C-724A-46DE-A0A4-A0D52CDFA7ABQ33361835-5FFE9594-91F9-4BB9-A8E8-B8B968CD0C37Q33640597-2CA23B53-0857-408C-8D93-DDAEB7007E92Q33653996-3841A983-5799-4127-8FEB-FF7A8FAAE761Q33894360-C2B44382-6ED7-496F-8192-D7C865CD0D4FQ34143918-28B1C7A5-A619-4384-A9F7-DFC9BECCC542Q34183204-FA1161B5-0969-4BA8-96DA-A978722AAD1CQ34317439-F629967C-E13B-4AB0-99D2-CB057618B7A4Q34351001-3AC881F9-A50D-4718-8079-A19299B67CE2Q34373108-8D078ACF-8F5B-4415-A327-DDE9B6E384B3Q34684165-580D66CA-9B10-4226-BAB9-27BA27CC8A2BQ34819311-8365E483-1587-4CCD-9E55-A9BD812E8E3DQ34820598-12585062-AF89-4209-8361-E6989AD5EA28Q34892327-091A1A4A-BE32-46C8-BA26-66077A770463Q35025204-C8B3188D-1987-4E3A-9D3B-36486C887AE4Q35063529-AB743F88-1CFD-4028-A87A-C2C38B0B6AD9Q35064952-09ABF778-CC9F-4EAB-862A-0620F657AC59Q35208132-A70EC271-3BF5-4F08-8EB9-98EA35A76F05Q35221382-C33E485E-F728-43E4-BC87-2156E04ED2EDQ35365484-B54A3389-1E49-4936-80CF-B940FBFC3D35Q35377964-F2E1C20D-F40B-4857-9BFB-C953AF7DA5B3Q35418431-2F846A75-25E0-4D1A-AB50-9445BD8D1CE4Q35642667-16349245-AC26-49CD-ADBE-CBA72D283FB7
P2860
Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients
@ast
Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients
@en
type
label
Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients
@ast
Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients
@en
prefLabel
Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients
@ast
Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients
@en
P2093
P2860
P1433
P1476
Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients
@en
P2093
Daniel Bergemalm
Johan Jacobsson
Karin Forsberg
Karin S Graffmo
Magnus Hultdin
P Andreas Jonsson
Roland Rosquist
Stefan L Marklund
Thomas Brännström
P2860
P304
P356
10.1371/JOURNAL.PONE.0011552
P407
P577
2010-07-14T00:00:00Z